Execution Of JV And Share Transfer Agreement For Transfer Of Kyorin Pharmaceutical's Generic Drug Business To JV By Daito, Meiji Seika Pharma And Dbj
30/09/2026 07:35
BRIEF-Daito Pharmaceutical Co Ltd - Execution Of JV And Share Transfer Agreement For Transfer Of Kyorin Pharmaceutical's Generic Drug Business To JV By Daito, Meiji Seika Pharma And Dbj Sept 30 (Reuters) - Daito Pharmaceutical Co Ltd 4577.T:
DAITO PHARMACEUTICAL CO LTD - EXECUTION OF JV AND SHARE TRANSFER AGREEMENT FOR TRANSFER OF KYORIN PHARMACEUTICAL'S GENERIC DRUG BUSINESS TO JV BY DAITO, MEIJI SEIKA PHARMA AND DBJ
Source text: ID:nTSud84757
Further company coverage: 4577.T
Recent news on Daito Pharmaceutical
See all newsTo Buy Back Up To 4.4% Of Own Shares Worth 2 Billion Yen
Table: Daito Pharmaceutical -Q1 group results
Execution Of JV And Share Transfer Agreement For Transfer Of Kyorin Pharmaceutical's Generic Drug Business To JV By Daito, Meiji Seika Pharma And Dbj
Table: Daito -2025/26 parent results
Table: Daito -2025/26 group results